Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Cash received from interests, fees and commissions | 44.34%15.29B | 22.62%8.88B | 21.37%4.36B | 13.38%16.51B | -5.16%10.6B | -14.34%7.24B | 4.15%3.59B | -8.94%14.56B | -8.89%11.17B | 5.81%8.46B |
| Net increase in repurchase business capital | --2.1B | --3.43B | --11.09B | ---- | ---- | ---- | ---- | 106.77%17.6B | -10.47%12.9B | 139.92%13.21B |
| Net increase in funds disbursed | --4.06B | --7.04B | 345.45%980M | ---- | ---- | ---- | --220M | ---- | ---- | ---- |
| Net cash received from trading securities | -32.93%23.86B | 130.63%11.66B | -81.81%1.27B | --34.59B | --35.57B | 105.68%5.05B | 209.73%6.98B | ---- | ---- | 868.05%2.46B |
| Net cash received from agency underwriting securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --44M | ---- | ---- |
| Cash received relating to other operating activities | -20.09%29.97B | 43.84%10.09B | 141.94%15.71B | -32.51%6.64B | 419.06%37.51B | 94.13%7.01B | 26.91%6.49B | 221.44%9.83B | -50.45%7.23B | -24.10%3.61B |
| Special items of operating cash inflws | ---- | 11.91%21.12B | ---- | --35.14B | ---- | --18.87B | ---- | ---- | ---- | ---- |
| Cash inflows from operating activities | -10.03%75.28B | 56.40%64.21B | 93.26%33.41B | 120.94%92.88B | 167.39%83.68B | 15.54%41.06B | -6.13%17.29B | -5.44%42.04B | -24.14%31.29B | 36.93%35.53B |
| Staff behalf paid | 14.82%4.89B | 9.31%3.53B | 7.43%2.27B | -2.85%5.74B | -7.58%4.26B | -5.71%3.23B | -8.40%2.11B | -2.07%5.91B | -2.40%4.61B | 2.01%3.43B |
| All taxes paid | 343.86%2.35B | 104.17%1.23B | 297.62%901.63M | -43.55%1.01B | -65.74%529.2M | -41.51%603.68M | -31.24%226.76M | -12.14%1.78B | -14.80%1.54B | 0.42%1.03B |
| Cash paid for fees and commissions | 13.25%4.38B | 1.65%2.64B | 1.49%1.39B | 6.71%5.27B | 1.46%3.86B | 5.13%2.6B | 11.27%1.37B | 10.78%4.94B | 9.29%3.81B | 6.02%2.47B |
| Net increase in financial assets held for trading purposes | --11.64B | ---- | 2,716.38%16.57B | ---- | ---- | ---- | -24.80%588.45M | ---- | -71.86%5.53B | ---- |
| Cash paid relating to other operating activities | 41.01%26.53B | 47.74%2.73B | 79.23%6.9B | -25.89%5.53B | -46.49%18.82B | -1.06%1.85B | -79.34%3.85B | 0.49%7.46B | 15.92%35.17B | -24.71%1.87B |
| Special items of operating cash outflws | ---- | 507.02%21.81B | ---- | -79.80%12.4B | ---- | -77.97%3.59B | ---- | 157.86%61.4B | ---- | 53.24%16.31B |
| Cash outflows from operating activities | 81.27%49.79B | 72.71%31.95B | 243.94%28.04B | -34.22%59.13B | -45.77%27.47B | -45.77%18.5B | -64.99%8.15B | 73.55%89.89B | -15.58%50.66B | -17.57%34.12B |
| Net cash flows from operating activities | -54.65%25.49B | 43.03%32.26B | -41.22%5.37B | 170.52%33.75B | 390.28%56.21B | 1,491.21%22.55B | 287.53%9.13B | -551.85%-47.86B | -3.25%-19.36B | 109.18%1.42B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -78.57%37.5M | -52.02%31.67M | -93.53%3.02M | 652.16%191.23M | 250.29%175.02M | 1,459.06%66M | 12,803.52%46.62M | -76.71%25.42M | -54.67%49.96M | -98.10%4.23M |
| Cash received from returns on investments | -95.27%11.92M | -95.25%11.92M | -98.51%25.48K | -26.34%252.72M | -20.20%252.09M | -19.62%251.02M | --1.71M | -34.85%343.11M | -34.29%315.92M | -3.61%312.29M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 32.93%3.21M | 92.25%3.48M | -50.65%1.1M | -41.26%2.01M | -49.75%2.41M | -9.38%1.81M | -12.75%2.23M | -47.77%3.42M | -21.90%4.8M | 32.67%2M |
| Cash received relating to other investing activities | --4.6B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 984.04%4.66B | -85.24%47.07M | -91.81%4.14M | 19.90%445.96M | 15.87%429.52M | 0.10%318.83M | 1,631.75%50.56M | -42.10%371.95M | -37.92%370.68M | -41.86%318.52M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -13.20%209.78M | -28.62%133.01M | -31.09%62.02M | -21.35%326.72M | -18.57%241.7M | -4.50%186.35M | -2.84%90.01M | -30.28%415.44M | -28.29%296.81M | -42.32%195.13M |
| Cash paid to acquire investments | 309.35%102M | 273.23%93M | ---- | -48.34%53.2M | -27.32%24.92M | --24.92M | -76.52%22.52M | 73.81%102.98M | -62.07%34.29M | ---- |
| Cash outflows from investing activities | 16.94%311.78M | 6.98%226.01M | -44.88%62.02M | -26.71%379.93M | -19.48%266.62M | 8.27%211.26M | -40.32%112.53M | -20.86%518.42M | -34.71%331.1M | -43.98%195.13M |
| Net cash flows from investing activities | 2,566.78%4.34B | -266.35%-178.93M | 6.59%-57.88M | 145.08%66.03M | 311.61%162.91M | -12.83%107.57M | 66.62%-61.97M | -1,049.15%-146.47M | -56.04%39.58M | -38.16%123.4M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --10B | --6B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from bonds issue | 40.59%72.59B | -27.65%26.58B | -36.12%13.64B | -9.22%105.63B | -24.18%51.64B | -18.83%36.74B | -24.97%21.35B | 86.68%116.35B | 21.62%68.11B | -14.18%45.26B |
| Cash from borrowing | 66.67%612.95M | 161.47%553.48M | 388.79%224.82M | 153.76%622.68M | 77.01%367.76M | 15.35%211.68M | -52.12%46M | -53.25%245.38M | -51.96%207.76M | 11.11%183.5M |
| Cash inflows from financing activities | 60.00%83.21B | -10.33%33.13B | -35.21%13.86B | -8.87%106.25B | -23.88%52B | -18.69%36.95B | -25.06%21.39B | 60.05%116.6B | 2.80%68.32B | -21.52%45.45B |
| Borrowing repayment | 14.42%74.07B | 6.78%45.65B | 1.69%19.68B | 45.27%94.45B | 28.51%64.74B | 6.16%42.75B | -4.46%19.35B | 3.77%65.02B | 5.67%50.38B | 12.06%40.27B |
| Dividend interest payment | 10.85%6.64B | 20.14%5.37B | 13.81%826.9M | 13.58%7.05B | 6.52%5.99B | 3.03%4.47B | -8.51%726.56M | -23.31%6.21B | -23.62%5.62B | -29.29%4.34B |
| Cash payments relating to other financing activities | -13.17%151.55M | -15.86%118.2M | 22.53%54.53M | -14.36%265.71M | -21.19%174.54M | -16.99%140.48M | -21.81%44.5M | 18.28%310.28M | 24.43%221.46M | 3.63%169.23M |
| Cash outflows from financing activities | 14.05%80.87B | 7.97%51.14B | 2.17%20.56B | 42.27%101.77B | 26.12%70.91B | 5.77%47.37B | -4.66%20.13B | 0.74%71.53B | 1.83%56.22B | 6.02%44.78B |
| Net cash flows from financing activities | 112.39%2.34B | -72.92%-18.01B | -629.57%-6.7B | -90.05%4.48B | -256.26%-18.9B | -1,674.06%-10.42B | -82.98%1.27B | 2,341.62%45.06B | 7.59%12.1B | -95.78%661.71M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 311.96%44.81M | -271.34%-28.25M | -635.58%-5.97M | 248.84%4.74M | -132.80%-21.14M | -109.56%-7.61M | 102.41%1.11M | -101.26%-3.18M | -75.49%64.47M | -32.32%79.54M |
| Net increase in cash and cash equivalents | -13.95%32.22B | 14.74%14.04B | -113.53%-1.4B | 1,401.79%38.3B | 622.76%37.45B | 436.30%12.24B | 342.92%10.34B | 44.03%-2.94B | -0.09%-7.16B | 319.78%2.28B |
| Add:Begin period cash and cash equivalents | 50.12%114.72B | 50.12%114.72B | 50.12%114.72B | -3.71%76.42B | -3.71%76.42B | -3.71%76.42B | -3.71%76.42B | -6.21%79.36B | -6.21%79.36B | -6.21%79.36B |
| End period cash equivalent | 29.05%146.94B | 45.24%128.76B | 30.62%113.32B | 50.12%114.72B | 57.72%113.86B | 8.59%88.65B | 6.20%86.75B | -3.71%76.42B | -6.80%72.19B | -4.13%81.64B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.